People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Health Care, Biotechnology, Pharmaceuticals, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Proteus Biomedical Inc | — | Other Health Care | Series D+ | $162.4M | $2.7B | 2009 |
| Kona Medical, Inc. | — | Biotechnology | Series B | $61.6M | $396.9M | 2010 |
| TearScience, Inc. | — | Pharmaceuticals | Series B | $58.9M | $653.7M | 2016 |
| ExplORer Surgical Corp. | — | Medical Devices | Series A | $11.2M | $45.8M | 2017 |
| Clear Vascular, Inc. | — | Biotechnology | Series A | $8.9M | $11.2M | 2009 |
| Serene Oncology, LLC | — | Biotechnology | Seed | $1.8M | $12.0M | 2011 |
Immanuel Thangaraj at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Immanuel Thangaraj on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jim Dougherty | 2 | 2 |
| Gilbert Gonzales | 2 | 2 |
| Jacques Krasny | 2 | 2 |
| Joel Cutler | 1 | 16 |
| Brian Halak | 1 | 10 |
| Peter Cohn | 1 | 10 |
| Ned Scheetz | 1 | 8 |
| Todd Davis | 1 | 8 |
| Henry A. Plain, Jr. | 1 | 7 |
| Alan Levy | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Terry Gould | 1 | 6 |
| Hank Plain | 1 | 5 |
| Frank Fischer | 1 | 5 |
| Joe Mandato | 1 | 5 |
| Todd Thompson | 1 | 4 |
| Geoff R. Pardo | 1 | 4 |
| Andrew Thompson | 1 | 3 |
| Louis Cannon | 1 | 3 |
| Abhijeet Lele | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.